- Home
- STRO vs HYI Comparison
STRO vs HYI Comparison
Compare STRO & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- HYI
- Stock Information
- Founded
- STRO 2003
- HYI 2010
- Country
- STRO United States
- HYI United States
- Employees
- STRO N/A
- HYI N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- HYI Investment Managers
- Sector
- STRO Health Care
- HYI Finance
- Exchange
- STRO Nasdaq
- HYI Nasdaq
- Market Cap
- STRO 292.6M
- HYI 279.2M
- IPO Year
- STRO 2018
- HYI N/A
- Fundamental
- Price
- STRO $2.89
- HYI $12.01
- Analyst Decision
- STRO Strong Buy
- HYI
- Analyst Count
- STRO 7
- HYI 0
- Target Price
- STRO $12.14
- HYI N/A
- AVG Volume (30 Days)
- STRO 596.9K
- HYI 50.6K
- Earning Date
- STRO 11-13-2024
- HYI 01-01-0001
- Dividend Yield
- STRO N/A
- HYI 9.59%
- EPS Growth
- STRO N/A
- HYI N/A
- EPS
- STRO N/A
- HYI N/A
- Revenue
- STRO $160,955,000.00
- HYI N/A
- Revenue This Year
- STRO N/A
- HYI N/A
- Revenue Next Year
- STRO N/A
- HYI N/A
- P/E Ratio
- STRO N/A
- HYI N/A
- Revenue Growth
- STRO 230.90
- HYI N/A
- 52 Week Low
- STRO $2.13
- HYI $10.99
- 52 Week High
- STRO $6.13
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- STRO 32.85
- HYI 40.97
- Support Level
- STRO $4.01
- HYI $11.95
- Resistance Level
- STRO $4.60
- HYI $12.29
- Average True Range (ATR)
- STRO 0.36
- HYI 0.13
- MACD
- STRO -0.06
- HYI -0.02
- Stochastic Oscillator
- STRO 3.93
- HYI 17.72
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.